NIKKEI 225
38,487.90 +433.80 (+1.14%) HANG SENG
18,079.61 -150.59 (-0.83%) CRUDE OIL
76.68 -0.31 (-0.40%) GOLD FUTURES
2,345.80 0.00 (0.00%) DOW
38,686.32 +574.82 (+1.51%) Bitcoin GBP
53,250.86 +81.93 (+0.15%)
Fresenius SE & Co KGaA (FRE.HM)
| Previous close | 28.88 |
| Open | 28.89 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 28.89 - 28.89 |
| 52-week range | 24.00 - 31.15 |
| Volume | |
| Avg. volume | 709 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Investors five-year losses continue as Fresenius SE KGaA (ETR:FRE) dips a further 3.8% this week, earnings continue to decline
The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results...
- Reuters
UPDATE 2-Fresenius raises outlook on strong quarterly results, exits Vamed
German healthcare group Fresenius first-quarter results beat expectations, the company said on Wednesday, citing strong performance at its Kabi and Helios businesses, prompting it to raise its full-year outlook. First-quarter earnings before interest and tax (EBIT) were 633 million euros ($680 million), above analysts' expectations of 606 million euros, according to a consensus of forecasts from Vara Research. In a bid to get leaner, Fresenius also said that it would sell its investment unit, Fresenius Vamed, completing its portfolio restructuring.
- Simply Wall St.
Institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the company
Key Insights Fresenius SE KGaA's significant retail investors ownership suggests that the key decisions are influenced...
